Riesgo de neurotoxicidad                                                               Risk of neurotoxicity 

Matzo M, Dawson KA. Opioid-induced neurotoxicity. Am J Nurs. 2013 113(10):51-6.

Smith EM. Current methods for the assessment and management of taxane-related neuropathy. Clin J Oncol Nurs. 2013 17 Suppl:22-34. doi: 10.1188/13.CJON.S1.22-34.

Brighton R, Moxham L, Traynor V. Support and services for people with alcohol-related brain injury. Aust Nurs J. 2012 20(3):36.

Benson G, McPherson A, Reid S. An alcohol withdrawal tool for use in hospitals. Nurs Times. 2012 108(26):15-7.

Bork CE, Rega PP. An assessment of nurses' knowledge of botulism. Public Health Nurs. 2012 29(2):168-74.

Steele D, Keltner NL, McGuiness TM. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? Perspect Psychiatr Care. 2011 47(1):58-62.

Davies MA, Conley Y, Roth BL. Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs. Biol Res Nurs. 2011 13(1):55-60.

Howland RH. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs. J Psychosoc Nurs Ment Health Serv. 2010 48(8):11-4.

Agar L. Recognizing neuroleptic malignant syndrome in the emergency department: a case study. Perspect Psychiatr Care. 2010 46(2):143-51.

Riddle E, Bush J, Tittle M, Dilkhush D. Alcohol withdrawal: development of a standing order set. Crit Care Nurse. 2010 30(3):38-47.

Johnson JM. Last call: ethanol metabolism and the implications for emergency department clinicians managing patients with extreme ethanol intoxication. Adv Emerg Nurs J. 2009 31(3):221-7.

Brown J, McColm R, Aindow J, Anderson J. Nursing assessment and management of alcohol-related brain damage in young people. Nurs Times. 2009 105(41):20-3.

Myers JS, Pierce J, Pazdernik T. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncol Nurs Forum. 2008 35(6):916-20.

Nguyen L. Lithium II: irreversible neurotoxicity after lithium intoxication. J Emerg Nurs. 2008 34(4):378-9.

Smith EM, Beck SL, Cohen J. The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2008 35(1):96-102.

Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum. 2007 34(5):997-1005.

Smith JR, Donze A, Schuller L. An evidence-based review of hyperbilirubinemia in the late preterm infant, with implications for practice: management, follow-up, and breastfeeding support. Neonatal Netw. 2007 26(6):395-405.

Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs. 2007 11(6):901-13.

Voepel-Lewis T, Mitchell A, Malviya S. Delayed postoperative agitation in a child after preoperative midazolam. J Perianesth Nurs. 2007 22(5):303-8.

Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum. 2007 34(5):981-94.

Visovsky C. The effects of neuromuscular alterations in elders with cancer. Semin Oncol Nurs. 2006 22(1):36-42.

Jones M, Bennett J, Gray R, Arya P, Lucas B. Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant. J Psychiatr Ment Health Nurs. 2006 13(1):26-32.

Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum. 2005 32(6):1151-63.

Visovsky CG. Peripheral nerve function and symptom distress during biotherapy for malignant melanoma. Can Oncol Nurs J. 2005 15(3):161-74.

Ward C. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study. J Neurosci Nurs. 2005 37(3):160-2.

Liu J, Wuerker A. Biosocial bases of aggressive and violent behavior--implications for nursing studies. Int J Nurs Stud. 2005 42(2):229-41.

Brandt D. Benzodiazepines, barbiturates, and nursing interventions. Am J Nurs. 2004 104(10):21.



Riesgo de progresión/recurrencia de neurotoxicidad                     Risk of neurotoxicity recurrence / progression 

Martin-Richard M, Gallego R, Pericay C, Foncillas JG, Queralt B, Casado E, et al. Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study. Invest New Drugs. 2013 Sep 28. [Epub ahead of print] 

Matzo M, Dawson KA. Opioid-induced neurotoxicity. Am J Nurs. 2013 113(10):51-6. doi: 10.1097/01.NAJ.0000435351.53534.83. 

Vacca VM, Toland D. Neuroleptic malignant syndrome. Nursing. 2013 43(5):22-3. doi: 10.1097/01.NURSE.0000428705.58507.3d. 

Smith EM. Current methods for the assessment and management of taxane-related neuropathy. Clin J Oncol Nurs. 2013 17 Suppl:22-34. doi: 10.1188/13.CJON.S1.22-34. 

Brighton R, Moxham L, Traynor V. Support and services for people with alcohol-related brain injury. Aust Nurs J. 2012  20(3):36. 

McWhinney-Glass S, Winham SJ, Hertz DL, Yen Revollo J, Paul J, He Y, et al. Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity. Clin Cancer Res. 2013 Oct 4.

Bighin C, Pronzato P, Del Mastro L. Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients. Future Oncol. 2013 9(7):955-7. doi: 10.2217/fon.13.74. 

Gioulbasanis I, Pallis A, Vlachostergios PJ, Xyrafas A, Giannousi Z, Perdikouri IE et al. The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer. Lung Cancer. 2012 77(2):383-8. doi:10.1016/j.lungcan.2012.04.008. 

Chamberlain MC. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. J Neurooncol. 2012 109(1):143-8. doi: 10.1007/s11060-012-0880-x. 

Anand AK, Chaudhory AR, Aggarwal HN, Sachdeva PK, Negi PS, Sinha SN, et al. Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide. J Cancer Res Ther. 2012 8(1):50-6. doi: 10.4103/0973-1482.95174. 

Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer. 2012 15;118(8Suppl):2250-60. doi: 10.1002/cncr.27463. 

Haile Y, Simmen KC, Pasichnyk D, Touret N, Simmen T, Lu JQ, et al. Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicity. J Immunol. 2011 Nov 1;187(9):4861-72. doi: 10.4049/jimmunol.1100943. 

Buch S, Yao H, Guo M, Mori T, Su TP, Wang J. Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J Neuroimmune Pharmacol. 2011 6(4):503-15. doi: 10.1007/s11481-011-9297-0.

Versión para imprimir Versión para imprimir | Mapa del sitio